Authors:
Burt, RK
Fassas, A
Snowden, JA
van Laar, JM
Kozak, T
Wulffraat, NM
Nash, RA
Dunbar, CE
Arnold, R
Prentice, G
Bingham, S
Marmont, AM
McSweeney, PA
Citation: Rk. Burt et al., Collection of hematopoietic stem cells from patients with autoimmune diseases, BONE MAR TR, 28(1), 2001, pp. 1-12
Authors:
Bingham, S
Griffiths, B
McGonagle, D
Snowden, JA
Morgan, G
Emery, P
Citation: S. Bingham et al., Autologous stem cell transplantation for rapidly progressive Jo-1-positivepolymyositis with long-term follow-up, BR J HAEM, 113(3), 2001, pp. 840-841
Citation: Ja. Snowden et Pm. Brooks, Risk taking in patients with rheumatoid arthritis: are the risks of haemopoietic stem cell transplantation acceptable? Reply, RHEUMATOLOG, 39(6), 2000, pp. 681-682
Authors:
Snowden, JA
Hill, GR
Hunt, P
Carnoutsos, S
Spearing, RL
Espiner, E
Hart, DNJ
Citation: Ja. Snowden et al., Assessment of cardiotoxicity during haemopoietic stem cell transplantationwith plasma brain natriuretic peptide, BONE MAR TR, 26(3), 2000, pp. 309-313
Authors:
Snowden, JA
Nivison-Smith, I
Atkinson, K
Fay, K
Concannon, A
Dodds, A
Milliken, S
Biggs, J
Citation: Ja. Snowden et al., Allogeneic PBPC transplantation: an effect on incidence and distribution of chronic graft-versus-host disease without long-term survival benefit?, BONE MAR TR, 25(1), 2000, pp. 119-120
Authors:
Snowden, JA
Nivison-Smith, I
Biggs, JC
Brooks, PM
Citation: Ja. Snowden et al., Risk taking in patients with rheumatoid arthritis: are the risks of haemopoietic stem cell transplantation acceptable?, RHEUMATOLOG, 38(4), 1999, pp. 321-324
Authors:
Tyndall, A
Fassas, A
Passweg, J
de Elvira, CR
Attal, M
Brooks, P
Black, C
Durez, P
Finke, J
Forman, S
Fouillard, L
Furst, D
Holmes, JA
Joske, D
Jouet, JP
Kotter, I
Locatelli, F
Prentice, HG
Marmont, AM
McSweeney, P
Musso, M
Peter, HH
Snowden, JA
Sullivan, K
Tichelli, A
Vavriec, J
Wulffraat, NM
Schmitz, N
Gratwohl, A
Citation: A. Tyndall et al., Autologous haematopoietic stem cell transplants for autoimmune disease - feasibility and transplant-related mortality, BONE MAR TR, 24(7), 1999, pp. 729-734
Authors:
Snowden, JA
Biggs, JC
Milliken, ST
Fuller, A
Brooks, PM
Citation: Ja. Snowden et al., A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis, ARTH RHEUM, 42(11), 1999, pp. 2286-2292
Authors:
Snowden, JA
Biggs, JC
Milliken, ST
Fuller, A
Staniforth, D
Passuello, F
Renwick, J
Brooks, PM
Citation: Ja. Snowden et al., A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis, BONE MAR TR, 22(11), 1998, pp. 1035-1041
Authors:
Snowden, JA
Nink, V
Cooley, M
Zaunders, J
Keir, M
Wright, L
Milliken, ST
Brooks, PM
Biggs, JC
Citation: Ja. Snowden et al., Composition and function of peripheral blood stem and progenitor cell harvests from patients with severe active rheumatoid arthritis, BR J HAEM, 103(3), 1998, pp. 601-609